Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC)-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC)

Published:2019-06-21 Issue:7 Volume:28 Page:583-592
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Babiker Hani M¹,Karass Michael²,Recio-Boiles Alejandro¹,Chandana Sreenivasa R³,McBride Ali⁴,Mahadevan Daruka¹

Affiliation:

1. Early Phase Clinical Trials Program, University of Arizona Cancer Center, Tucson, AZ, USA

2. New York Medical College, Westchester Medical Center, Valhalla, NY, USA

3. Department of Hematology-Oncology, Phase I Program, START Midwest, Grand Rapids, MI, USA

4. Department of Pharmacy, University of Arizona Cancer Center, Tucson, AZ, USA

Funder

National Cancer Institute

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2019.1632289

Reference52 articles.

1. Predictive global trends in the incidence and mortality of pancreatic cancer based on geographic location, socio-economic status, and demographic shift

2. Epidemiology of pancreatic cancer

3. Cancer statistics, 2018

4. Validation of the American Joint Commission on Cancer (AJCC) 8th Edition Staging System for Patients with Pancreatic Adenocarcinoma: A Surveillance, Epidemiology and End Results (SEER) Analysis

5. Pancreatic Adenocarcinoma, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MYC and KRAS cooperation: from historical challenges to therapeutic opportunities in cancer;Signal Transduction and Targeted Therapy;2024-08-21

2. The Molecular Twin artificial-intelligence platform integrates multi-omic data to predict outcomes for pancreatic adenocarcinoma patients;Nature Cancer;2024-01-22

3. Multi-targeting liposomal codelivery of cisplatin and rapamycin inhibits pancreatic cancer growth and metastasis through stromal modulation;International Journal of Pharmaceutics;2023-09

4. Targeting Pancreatic Cancer with Novel Plumbagin Derivatives: Design, Synthesis, Molecular Mechanism, In Vitro and In Vivo Evaluation;Journal of Medicinal Chemistry;2023-05-31

5. Reshaping the Pancreatic Cancer Microenvironment at Different Stages with Chemotherapy;Cancers;2023-04-25

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3